Literature DB >> 282051

Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension.

J A Lopez-Ovejero, M A Weber, J I Drayer, J E Sealey, J H Laragh.   

Abstract

1. Indomethacin was administered alone or in addition to either diuretic or propranolol therapy to three groups of patients with essential hypertension on a free sodium diet. 2. Indomethacin administration reduced renin secretion by about 30% in untreated uncomplicated hypertensive patients and by about 75% in those whose renin secretion had either been stimulated or suppressed by maintained diuretic or beta-adrenoreceptor-blockade therapy. 3. Indomethacin administration produced no net effect on blood pressure in untreated patients with uncomplicated hypertension but it blunted or reversed the antihypertensive effect of either diuretic or propranolol therapy. 4. Salt and water retention may be an important factor in the blood pressure-raising effect of indomethacin during diuretic or propranolol therapy: In addition, prostaglandin synthesis may be important in counteracting increased alpha-adrenergic tone, which may limit the blood pressure-lowering effect of beta-adrenoreceptor-blockade. 5. Because of these interactions and their pressor potential indomethacin should be used with caution when combined with either diuretics or beta-adrenoreceptor blockers.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 282051     DOI: 10.1042/cs055203s

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN: 0144-4107


  19 in total

Review 1.  Nifedipine interactions in hypertensive patients.

Authors:  A Salvetti; A Magagna; B Abdel-Haq; M Lenzi; R Giovannetti
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 2.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  Double-blind study on the interaction of oxaprozin with metoprolol in hypertensives.

Authors:  A Halabi; M Linde; H Zeidler; J König; W Kirch
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

4.  Interaction of indomethacin and sulindac with labetalol.

Authors:  M A Abate; J L Neely; R D Layne; R D'Alessandri
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

5.  Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.

Authors:  A Salvetti; F Arzilli; R Pedrinelli; P Beggi; M Motolese
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 6.  Interactions of NSAIDs with diuretics and beta-blockers mechanisms and clinical implications.

Authors:  J Webster
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

7.  The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients.

Authors:  A Salvetti; R Pedrinelli; P Alberici; A Magagna; B Abdel-Haq
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

8.  Effects of non-steroidal anti-inflammatory drugs on prostacyclin and thromboxane biosynthesis in patients with mild essential hypertension.

Authors:  P Minuz; S E Barrow; J R Cockcroft; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

Review 9.  Do nonsteroidal anti-inflammatory drugs interfere with blood pressure control in hypertensive patients?

Authors:  K Radack; C Deck
Journal:  J Gen Intern Med       Date:  1987 Mar-Apr       Impact factor: 5.128

10.  Indomethacin does not attenuate the effects of hydralazine in normal subjects.

Authors:  S H Jackson; H Pickles
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.